Information & Learning Outcomes

Title Adam Smith’s breathlessness and syncope
Author Dr Nabeel Sheikh
Stage 2
Module Science to Clinical Practice 2
Block Vascular
Block Learning Outcomes this scenario addresses

Outcomes for Graduates ref. in parentheses

Students should be able to

  • 1. Apply their knowledge of the normal anatomy and physiology of the heart and vascular system to explain the pathophysiology of the heart and vascular system and the scientific basis of therapeutics of cardiac disease. [8a, 8b, 8e, 8f, 17b]
  • 7. Describe cardiovascular epidemiology, genetics and risk factors, considering how the diversity of the population determines the pattern of presentations in the UK and globally. [11a, 11f, 11j]
  • 8. Apply understanding of the relative merits of imaging technologies as tools for clinical investigation to contribute to the development of a plan of investigation and treatment. [8c, 8d, 14c]
  • 10. Demonstrate understanding of the importance of lifestyle and behaviors on cardiovascular risk. [9a, 9d, 10d, 11b, 11g, 11h]
  • 11. Demonstrate the use and interpretation of cardiovascular risk calculation tools; their applications and limitations. [8g, 11c, 11f, 11i, 12a, 13g, 14f, 15h, 17b, 19d, 19e, 20b, 23c]
  • 12. Demonstrate understanding of the socioeconomic consequences of cardiovascular disease, and the role of doctors and other members of the healthcare team in primary, secondary and tertiary prevention of cardiovascular disease. [9e, 10b, 10d, 10e, 11a, 11b, 11d, 11f, 11g, 11h, 11i, 12a, 12b, 12c, 12d, 12g]
  • 13. Observe a member of the healthcare team discussing behaviour change with patients with vascular disease, analyse the factors that enhance the success of these conversations; undertake observed behaviour change conversations with patients and receive and reflect on feedback provided. [9e, 10e, 13e, 13g, 14g, 14h, 15d, 19d, 20b, 21c, 22b]
  • 15. Apply knowledge of disease processes, pathophysiology and therapeutics to examine national guidelines for the use of preventative medication to reduce cardiovascular risk and evaluate their relevance for individual patients, taking into account a risk-benefit analysis. [8e, 8f, 11d, 11f, 12a, 12c, 14g, 17f, 19e, 20b, 23c]
  • 21. Demonstrate competence in the auscultation of heart sounds and be able to relate the examination findings to the relevant anatomy and pathophysiology. [8a, 8b, 8g, 8c, 14a]
  • 22. Clerk a patient with a vascular condition, consider the differential diagnosis with a clinical teacher and evaluate options for the investigation of the patient before developing an investigation plan. [8c, 8d, 13a, 13c, 13d, 14a, 14b, 14c]
  • 23. Clerk a vascular patient and contribute the findings to a multidisciplinary care planning meeting, considering the role of self-care and non-health agencies in promoting treatment and recovery. [9b, 9e, 9f, 10d, 10e, 13a, 13b, 13c, 13d, 13f, 13g, 14f, 14g, 14h, 15a, 20b, 22a, 22b, 22c, 23g]
  • 24. Review the clinical decision making processes in relation to the care of an individual patient and recommend improvements in the care planning process. [21c, 23a, 23d, 23e, 23g]
  • 25. Observe and participate in the assessment and early management of acutely unwell patients with vascular disorders, and discuss the role of team members in this process. [13a, 13c, 14a-g, 16a, 16b, 6c, 16d, 16e, 22a, 22b, 22c, 22d, 23a, 23b]
  • 26. Define and quantify the measurement error in clinical diagnosis and diagnostic tests for vascular disease; and discuss the concepts of validity and reliability. [8g, 11c, 12a]
Primary Patient condition this scenario relates to: Hypertrophic Cardiomyopathy
Creation Date February 2018
Review Date February 2019